Home News Health and Wellness. The 35th European Congress of Pathology (ECP), taking place September 9-13 in Dublin, Ireland, is a focal point for pathologists from over 100 countries and serves as a platform for the latest advancements in the field. Illumina is hosting a symposium focusing on the significance of comprehensive genomic profiling (CGP) and the incorporation of rare biomarkers into routine clinical practice.

A team of researchers at the Broad Institute of MIT and Harvard has developed a new approach to next-generation sequencing that detects genetic mutations within single molecules of DNA. The method, called Concatenating Original Duplex for Error Correction (CODEC), makes next-generation sequencing about 1,000 times more accurate and opens up the possibility of a range of applications including detecting tiny numbers of cancer mutations in blood samples, monitoring cancer during and after treatment, and identifying mutations underlying rare diseases, all at relatively low cost.

This panel session is fortunate to include the father of a child affected by Leber hereditary optic neuropathy (LHON) and will open with the perspective of a parent and active patient advocate. Post this The speakers will address advances in trial design specific to rare/genetic diseases...